Florian Brand is the founder of ATAI Life Sciences. ATAI Life Sciences has raised $600M in total funding. Latest round: IPO. Based in Berlin, Germany.
Florian Brand is the co-founder and Chief Executive Officer of ATAI Life Sciences, a global biotech company focused on developing psychedelic-based treatments for mental health disorders. Since becoming CEO in 2018, he has led the company to raise over $600 million, grow its staff to more than 100 employees, advance eight compounds into clinical-stage trials, and take ATAI public on the Nasdaq in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library